Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Express Scripts
Medtronic
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sarcosine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Sarcosine: Sponsors, patents, clinical trial progress

Sarcosine is an investigational drug.

There have been 14 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.

There are two US patents protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Sarcosine
TitleSponsorPhase
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTUniversity of AarhusEarly Phase 1
Carbon-11 Labeled Sarcosine in Prostate CancerNational Cancer Institute (NCI)N/A
Carbon-11 Labeled Sarcosine in Prostate CancerNational Institutes of Health (NIH)N/A

See all Sarcosine clinical trials

Clinical Trial Summary for Sarcosine

Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine

See all Sarcosine clinical trials

US Patents for Sarcosine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sarcosine   Start Trial Mild skin cleansing aerosol mousse with skin feel and moisturization benefits The Procter & Gamble Company (Cincinnati, OH)   Start Trial
Sarcosine   Start Trial Delivery system Alza Corporation (Palo Alto, CA)   Start Trial
Sarcosine   Start Trial Compositions containing phosphonitrile chlorides Wacker-Chemie GmbH (Munich, DE)   Start Trial
Sarcosine   Start Trial General method for producing and selecting peptides with specific properties The Regents of the University of California (Oakland, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sarcosine

Drugname Country Document Number Estimated Expiration Related US Patent
Sarcosine Austria 52185 2005-03-01   Start Trial
Sarcosine Australia 5422186 2005-03-01   Start Trial
Sarcosine Australia 590745 2005-03-01   Start Trial
Sarcosine Canada 1266439 2005-03-01   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
AstraZeneca
Johnson and Johnson
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.